ISEE
IVERIC bio, Inc.
24.17
+
0.46
1.94%
9 x 22.27
13 x 24.62
bid
ask
11 @ 04:00 PM
24.01-0.16 (0.66%)


sentiment
23.57
day range
24.52
9.12
52 week range
24.56
Prev Close23.71
Open23.90
Low23.57
High24.52
Volume1.56M
Avg. Volume2.42M
Market Cap3.31B
Inst. Own109.58%
Beta1.10
Short Ratio3.31
Div & Yield0.00 /
EPS-1.51
P/E
1yr Target31.17
50day MA21.91
200day MA17.83
^DJI
Dow Jones Industrial Average
32237.50
05:02 PM
+
132.30
0.41%
^IXIC
NASDAQ Composite
11824.00
05:15 PM
+
36.60
0.31%
^GSPC
S&P 500
3970.99
05:02 PM
+
22.27
0.56%
AAPL
160.23
-0.02 (0.01%)
Apple Inc.
160.25
8 @ 04:00 PM
8 x 160.20
8 x 160.03
+
1.32
0.83%
GOOG
106.50
+0.44 (0.41%)
Alphabet Inc.
106.06
10 @ 04:00 PM
10 x 106.30
9 x 106.29
-
0.20
0.19%
AMZN
98.44
+0.31 (0.32%)
Amazon.com, Inc.
98.13
12 @ 04:00 PM
10 x 98.42
13 x 98.35
-
0.58
0.59%
MSFT
280.94
+0.37 (0.13%)
Microsoft Corporation
280.57
9 @ 04:00 PM
8 x 280.94
9 x 280.96
+
2.91
1.05%
BABA
87.17
+0.27 (0.31%)
Alibaba Group Holding Limited
86.90
12 @ 04:02 PM
14 x 87.03
10 x 87.50
+
0.38
0.44%
NFLX
329.70
+1.31 (0.40%)
Netflix, Inc.
328.39
19 @ 04:00 PM
30 x 329.00
8 x 328.69
+
8.02
2.50%
TSLA
190.21
-0.20 (0.11%)
Tesla, Inc.
190.41
12 @ 04:00 PM
12 x 190.21
12 x 190.19
-
1.81
0.94%
NVDA
267.70
-0.09 (0.03%)
NVIDIA Corporation
267.79
11 @ 04:00 PM
14 x 267.70
8 x 267.71
-
4.12
1.52%
AMD
98.18
+0.23 (0.23%)
Advanced Micro Devices, Inc.
97.95
8 @ 04:00 PM
8 x 98.06
8 x 98.20
-
2.33
2.32%
MU
61.33
+0.17 (0.28%)
Micron Technology, Inc.
61.16
25 @ 04:00 PM
31 x 61.20
18 x 61.48
-
0.18
0.29%
SPY
396.46
+0.71 (0.18%)
SPDR S&P 500 ETF Trust
395.75
12 @ 04:00 PM
14 x 396.42
9 x 396.50
+
2.58
0.66%
TQQQ
25.93
+0.11 (0.43%)
ProShares UltraPro QQQ
25.82
339 @ 04:00 PM
270 x 25.89
407 x 25.90
+
0.26
1.02%
BRK-A
442765.00
-10301.00 (2.27%)
Berkshire Hathaway Inc.
453066.00
10 @ 04:02 PM
12 x 450000.00
8 x 456887.00
+
316.00
0.07%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Here’s Why You Should Add IVERIC bio (ISEE) to Your Watchlist | news.google.com • |
These Are the Top 10 Holdings of David Kim | 247wallst.com • |
Why Is Iveric Bio (ISEE) Stock Up 25% Today? | investorplace.com • |
IVERIC bio, Inc. (ISEE) Q3 2022 Earnings Call Transcript | seekingalpha.com • |
Iveric Bio to Present at Upcoming Investor Conferences | businesswire.com • |
Apellis Pharma Crashes On Unexpected Delay For Eye Drug — A Boon For Iveric Bio | investors.com • |
Profile
...
IVERIC bio, Inc., a biopharmaceutical company, focuses on the discovery and development of novel treatments for retinal diseases with unmet medical needs. The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; GATHER2 that is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD); and STAR or OPH2005 that is in Phase 2b clinical trial for the treatment of autosomal recessive Stargardt disease. Its preclinical product candidatures include IC-500, a high temperature requirement A serine peptidase 1 protein inhibitors for the treatment of GA and other age-related retinal diseases. The company also develops OPH2001 that has completed Phase 1/2a clinical trial of various doses of avacincaptad pegol (ACP) administered as a monotherapy for the treatment of GA; OPH2000, which has completed Phase 1/2a clinical trial of various doses of ACP administered in combination with Lucentis for the treatment of wet AMD; OPH2007 that has completed Phase 2a clinical trial for the treatment of wet AMD; and OPH2002, which has completed Phase 2a clinical trial for the treatment of idiopathic polypoidal choroidal vasculopathy. In addition, its minigene programs comprises miniCEP290 program for LCA10; miniABCA4 Program for STGD1; and miniUSH2A Program for usher syndrome type 2A-Related inherited retinal diseases (IRDs). The company was formerly known as Ophthotech Corporation and changed its name to IVERIC bio, Inc. in April 2019. The company was incorporated in 2007 and is based in Parsippany, New Jersey.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-05-03 | 2023-03 | -0.45 | N/A | N/A | N/A |
2023-03-01 | 2022-12 | -0.37 | -0.47 | -0.1 | -27.03% |
2022-11-03 | 2022-09 | -0.4 | -0.35 | 0.05 | 12.50% |
2022-07-26 | 2022-06 | -0.31 | -0.41 | -0.1 | -32.26% |
2022-05-04 | 2022-03 | -0.29 | -0.29 | N/A | N/A |
2022-02-24 | 2021-12 | -0.24 | -0.29 | -0.05 | -20.83% |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-03-02 | HC Wainwright & Co. | Upgrade | Buy | |
2023-02-21 | B. Riley Securities | Upgrade | Neutral | |
2023-02-17 | HC Wainwright & Co. | Upgrade | Buy | |
2022-11-10 | Jefferies | Downgrade | Buy | Hold |
2022-11-04 | HC Wainwright & Co. | Upgrade | Buy | |
2022-09-08 | Stifel | Upgrade | Buy |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-07-14 | BLUMENKRANZ MARK S | Director | 17.50K | Conversion of Exercise of derivative security |
2023-01-02 | CARROLL DAVID FRANCIS | Chief Financial Officer | 68.47K | Sale |
2023-01-01 | DUGEL PRAVIN U | President | 148.72K | Conversion of Exercise of derivative security |
2022-12-12 | GIBNEY ANTHONY S. | Officer | 42.79K | Conversion of Exercise of derivative security |
2022-05-10 | GRAVES ADRIENNE L | Director | 7.50K | Conversion of Exercise of derivative security |
2023-01-04 | MILLER CHRISTINE ANN | Director | 5.00K | Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | Vanguard Group, Inc. (The) | 10.15M | 245.37M | 7.40% |
2022-12-30 | Blackrock Inc. | 9.75M | 235.69M | 7.11% |
2022-12-30 | Deep Track Capital, LP | 7.88M | 190.41M | 5.75% |
2022-12-30 | Avoro Capital Advisors LLC | 6.75M | 163.15M | 4.92% |
2022-12-30 | State Street Corporation | 6.34M | 153.16M | 4.62% |
2022-12-30 | Tcg Crossover Management, Llc | 5.14M | 124.26M | 3.75% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 3.81M | 92.16M | 3.16% |
2022-09-29 | Vanguard Total Stock Market Index Fund | 3.48M | 84.09M | 2.88% |
2022-12-30 | iShares Russell 2000 ETF | 3.06M | 73.92M | 2.53% |
2022-12-30 | Smallcap World Fund | 2.16M | 52.31M | 1.79% |
2022-09-29 | Price (T.Rowe) Health Sciences Fund | 1.61M | 38.81M | 1.33% |
2022-09-29 | Vanguard Extended Market Index Fund | 1.50M | 36.23M | 1.24% |
This topic has been deleted. Only users with topic management privileges can see it.
-
Take profits and head too $OCGN for there eye and Vaxx run next…
-
$ISEE me shorting this one……it’s going down
-
Only the big dogs know. Us retail slobs have to guess on the up one no news.
-
Good luck on the cash secured puts. I hope you don’t get burned. Almost too good to be true.
-
Something is Brewing.
-
Will it touch 11 or 9 first?
-
Why is this selling off so hard?
-
$ISEE you at $10!
-
-
Here’s Why You Should Add IVERIC bio (ISEE) to Your Watchlist
news.google.com • -
These Are the Top 10 Holdings of David Kim
247wallst.com • -
Why Is Iveric Bio (ISEE) Stock Up 25% Today?
investorplace.com • -
IVERIC bio, Inc. (ISEE) Q3 2022 Earnings Call Transcript
seekingalpha.com • -
Iveric Bio to Present at Upcoming Investor Conferences
businesswire.com • -
Why Is Iveric Bio (ISEE) Stock Up 56% Today?
investorplace.com • -
7 Cheap Biotech Stocks to Buy Now
investorplace.com • -
Trial Results Set to Make or Break Small-Cap Pharma Stocks
gurufocus.com • -
IVERIC bio: A First Take
seekingalpha.com • -
Biopharmaceutical Stocks: The Bottoming Process Is Playing Out
seekingalpha.com • -
Iveric Bio to Present at the UBS Global Healthcare Conference 2022
businesswire.com • -
Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks
benzinga.com • -
7 A-Rated Biotechs to Buy for the Long Run
investorplace.com • -
Apellis' Loss Is Iveric Bio's Gain In Lucrative Eye Disease Field
seekingalpha.com • -
ISEE Stock: Why It Significantly Increased Yesterday
pulse2.com • -
Why IVERIC Bio Shares Are Soaring Today
benzinga.com • -
Why Are Iveric Bio Shares Surging In Premarket Friday?
benzinga.com • -
New Strong Sell Stocks for August 18th
zacks.com • -
Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech
pennystocks.com • -
Iveric Bio Appoints Christopher Simms as Chief Commercial Officer
businesswire.com • -
IVERIC bio (ISEE) Enters Overbought Territory
zacks.com • -
IVERIC bio, Inc. Announces Proposed Offering of Common Stock
businesswire.com • -
IVERIC bio Stock Increased 11.87%: Why It Happened
pulse2.com • -
New Strong Sell Stocks for April 26th
zacks.com • -
New Strong Sell Stocks for April 21st
zacks.com • -
New Strong Sell Stocks for April 6th
zacks.com • -
David R. Guyer, MD to Step Down from Iveric Bio Board to Rejoin Venture Fund
businesswire.com • -
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com • -
Iveric Bio to Present at the Cowen 41st Annual Health Care Conference
businesswire.com • -
4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)
insidermonkey.com • -
IVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com • -
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com • -
Worsening eye sight doesn't stop for Covid, neither did we
irishtimes.com • -
Did Hedge Funds Make The Right Call On IVERIC bio, Inc. (ISEE) ?
finance.yahoo.com • -
Two Sigma Advisers LP Has $258,000 Stock Position in IVERIC bio Inc (NASDAQ:ISEE)
thelincolnianonline.com • -
17,273 Shares in IVERIC bio Inc (NASDAQ:ISEE) Purchased by JPMorgan Chase & Co.
thelincolnianonline.com • -
Moving Average Crossover Alert: IVERIC bio
finance.yahoo.com • -
Iveric's Trial Progress And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com • -
Iveric Bio: Pick Up Post-Fundraising Low And Hold For Good News
seekingalpha.com • -
Two Sigma Investments LP Invests $675,000 in IVERIC bio Inc (NASDAQ:ISEE)
thelincolnianonline.com • -
822,050 Shares in IVERIC bio Inc (NASDAQ:ISEE) Acquired by Deutsche Bank AG
thelincolnianonline.com • -
NOVARTIS AG : Buy rating from Oddo | MarketScreener
marketscreener.com • -
IVERIC bio Inc (NASDAQ:ISEE) Receives Consensus Rating of “Hold” from Analysts
thelincolnianonline.com • -
Specsavers stores have reopened for eye tests across Cambridgeshire
cambridge-news.co.uk • -
Is IVERIC bio, Inc. (ISEE) Going to Burn These Hedge Funds?
finance.yahoo.com •